Astrazeneca Pharma I - Quaterly Results

26 May 2022 Evaluate
The company witnessed a 10.32% growth in the revenue at Rs. 2319.63 millions for the quarter ended March 2022 as compared to Rs. 2102.57 millions during the year-ago period.Profit for the quarter ended March 2022 grew by 2.59% to Rs. 279.84 millions from Rs. 272.78 millions.The Operating Profit of the company witnessed a decrease to 416.45 millions from 429.62 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202203 202103 % Var 202203 202103 % Var 202203 202103 % Var
Sales 2319.63 2102.57 10.32 8056.00 8135.63 -0.98 8056.00 8135.63 -0.98
Other Income 36.84 25.53 44.30 147.58 128.41 14.93 147.58 128.41 14.93
PBIDT 416.45 429.62 -3.07 1009.33 1483.12 -31.95 1009.33 1483.12 -31.95
Interest 2.07 2.82 -26.60 9.47 10.93 -13.36 9.47 10.93 -13.36
PBDT 414.38 426.80 -2.91 999.86 1472.19 -32.08 999.86 1472.19 -32.08
Depreciation 44.07 58.42 -24.56 169.49 201.26 -15.79 169.49 201.26 -15.79
PBT 370.31 368.38 0.52 830.37 1270.93 -34.66 830.37 1270.93 -34.66
TAX 90.47 95.60 -5.37 214.43 337.90 -36.54 214.43 337.90 -36.54
Deferred Tax -1.67 10.11 -116.52 -11.86 -10.38 14.26 -11.86 -10.38 14.26
PAT 279.84 272.78 2.59 615.94 933.03 -33.98 615.94 933.03 -33.98
Equity 50.00 50.00 0.00 50.00 50.00 0.00 50.00 50.00 0.00
PBIDTM(%) 17.95 20.43 -12.14 12.53 18.23 -31.27 12.53 18.23 -31.27

Astrazeneca Pharma I Share Price

5651.00 -101.60 (-1.77%)
23-May-2024 15:30 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1494.95
Dr. Reddys Lab 5882.45
Cipla 1487.45
Zydus Lifesciences 1087.65
Lupin 1631.60
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.